David Sidransky is Director at Ayala Pharmaceuticals, Inc. (ADXS). They have made 6 open-market trades across 4 companies since 2014, most recently 2023-01-19.
CIK 0001100397
3 open-market purchases totalling $31K since 2014, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AYLA | BUY | 2020-05-08 | 2021-03-08 | $14.80 | $4K | -1.8% | -18.5% | -29.0% |
| ORGS | BUY | 2020-05-07 | 2021-01-11 | $5.96 | $1K | +25.0% | +32.2% | +2.6% |
| ADXS | SELL | 2016-08-09 | 2016-08-10 | $14.85 | $169K | -7.8% | -33.3% | -38.5% |
| ADXS | SELL | 2016-08-08 | 2016-08-10 | $15.01 | $342K | -7.8% | -33.3% | -38.5% |
| ADXS | SELL | 2016-08-08 | 2016-08-10 | $15.17 | $173K | -7.8% | -33.3% | -38.5% |
| IMNP | BUY | 2014-11-26 | 2014-12-03 | $2.50 | $26K | +2.0% | -15.3% | -15.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.